You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High-grade Neuroendocrine Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) Trial in San Francisco, Boston, New York (Pembrolizumab, Irinotecan,

Completed
Has Results
  • High Grade Malignant Neuroendocrine Carcinoma (Diagnosis)
  • San Francisco, California
  • +2 more
Dec 5, 2022

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)

Recruiting
  • NSCLC
  • +6 more
  • Oral MRT-2359
  • Scottsdale, Arizona
  • +7 more
Dec 20, 2022

Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

Not yet recruiting
  • Small-cell Lung Cancer
  • Neuroendocrine Carcinoma
  • (no location specified)
Jun 13, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma Trial in Xiamen, Harbin (Chidamide, Sintilimab)

Recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Xiamen, Fujian, China
  • +1 more
Nov 22, 2021

Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

Recruiting
  • Microsatellite High Cancers
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 8, 2022

Neuroendocrine Tumor Trial in Beijing (Sintilimab, IBI310, Surufatinib)

Recruiting
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
  • +1 more
Dec 7, 2021

Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)

Recruiting
  • Lung Small Cell Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

Recruiting
  • Genitourinary Cancer
  • +7 more
  • La Jolla, California
  • +5 more
Jul 5, 2022

Small Cell Carcinoma, NSCLC, Neuroendocrine Tumors Trial in United States (RRx-001, Cisplatin, Etoposide)

Active, not recruiting
  • Small Cell Carcinoma
  • +3 more
  • Palo Alto, California
  • +9 more
May 12, 2022

Cancer Trial in Germany (Avelumab)

Completed
  • Cancer
  • Halle (Saale), Germany
  • +3 more
Feb 24, 2022

Neuroendocrine Tumors Trial in Philadelphia, Houston (Pembrolizumab)

Completed
Has Results
  • Neuroendocrine Tumors
  • Philadelphia, Pennsylvania
  • +1 more
Feb 16, 2021

Neuroendocrine Tumors, Well-Differentiated Neuroendocrine Carcinoma, High Grade Neuroendocrine Carcinoma, Any Site Trial in San

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Feb 17, 2023

High Grade Neuroendocrine Tumors Trial in Saint Louis (Cabozantinib, Blood for plasma biomarkers, Tissue biopsy)

Recruiting
  • High Grade Neuroendocrine Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 11, 2021

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • [212Pb] VMT-α-NET
  • [203Pb] VMT-α-NET SPECT/CT
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

Enrolling by invitation
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumor Grade 1
  • Iowa City, Iowa
    The University of Iowa
Dec 9, 2022

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

Not yet recruiting
  • High Grade Serous Ovarian Cancer (HGSOC)
  • FAPI PET CT
  • (no location specified)
Jul 20, 2023

Right-sided Hemicolectomy for Chldren With High-risk

Recruiting
  • Neoplasms
  • Appendix Cancer
    • Amsterdam-Zuidoost, Netherlands
      Amsterdam UMC
    Jun 23, 2023

    Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

    Not yet recruiting
    • Ovarian Cancer
    • +6 more
    • (no location specified)
    Oct 27, 2022

    Neuroendocrine Tumor of Pancreas (Disorder), Neuroendocrine Tumor Grade 1 Trial in Marseille (Radiofrequency ablation)

    Recruiting
    • Neuroendocrine Tumor of Pancreas (Disorder)
    • Neuroendocrine Tumor Grade 1
    • Radiofrequency ablation
    • Marseille, France
      Institut Paoli Calmettes
    Jan 5, 2022

    Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

    Not yet recruiting
    • Ovarian Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023

    Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

    Recruiting
    • Neuroendocrine Tumor Grade 2
    • Neuroendocrine Tumors
    • Capecitabine Oral Product
    • +2 more
    • Little Rock, Arkansas
    • +2 more
    Aug 11, 2022

    New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

    Enrolling by invitation
    • Ovarian Cancer
    • +2 more
    • CRS scoring
    • Routine blood laboratory testing before treatment
    • Guangzhou, Guangdong, China
      The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Nov 2, 2023

    Recurrent High Grade Uterine Cancer Trial in United States (Paclitaxel, Batiraxcept)

    Not yet recruiting
    • Recurrent High Grade Uterine Cancer
    • San Francisco, California
    • +3 more
    Apr 11, 2023